The current pregnant women living with hiv antiretroviral therapy coverage for pmtct of Trinidad and Tobago is 92%, this is a decrease of 8% (-8.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Trinidad and Tobago
No matching regions
Data currently not available for this time and region, try a different time period
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Trinidad and Tobago
PMTCT antiretroviral therapy coverage
More indicators for Trinidad and Tobago
Male unintentional poisoning
0.1
0.0
(2019)
Female wasting in children
7.1%
2.5%
(2011)
Female prevalence of HIV
0.3%
0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar817
intl dollar59
(2021)
Birth registration
96.5%
0.1%
(2011)
Contraceptive modern method prevalence
37.6%
0.5%
(2011)
Trinidad and Tobago PMTCT antiretroviral therapy coverage between 2000 and 2022
Period | PMTCT antiretroviral therapy coverage | Change |
---|---|---|
2022 | 92% | 8% |
2021 | 100% | 0% |
2020 | 100% | 9% |
2019 | 91% | 0% |
2018 | 91% | 7% |
2017 | 84% | 0% |
2016 | 84% | 25% |
2015 | 59% | 5% |
2014 | 64% | 7% |
2013 | 71% | 21% |
2012 | 92% | 7% |
2011 | 85% | 19% |
2010 | 66% | 22% |
2009 | 44% | 11% |
2008 | 55% | 4% |
2007 | 51% | 4% |
2006 | 47% | 7% |
2005 | 40% | 6% |
2004 | 34% | 1% |
2003 | 35% | 6% |
2002 | 29% | 7% |
2001 | 22% | 13% |
2000 | 9% |